Gotham Asset Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,860
Closed -$295K 1016
2021
Q2
$295K Buy
+10,860
New +$265K 0.01% 850
2018
Q1
Sell
-27,707
Closed -$461K 937
2017
Q4
$461K Sell
27,707
-21,486
-44% -$367K 0.01% 723
2017
Q3
$841K Sell
49,193
-29,828
-38% -$501K 0.01% 629
2017
Q2
$1.28M Buy
79,021
+24,140
+44% +$382K 0.02% 600
2017
Q1
$952K Sell
54,881
-6,263
-10% -$105K 0.01% 678
2016
Q4
$1.03M Buy
61,144
+3,766
+7% +$62.8K 0.01% 615
2016
Q3
$1.01M Buy
57,378
+42,530
+286% +$690K 0.01% 602
2016
Q2
$213K Buy
+14,848
New +$186K ﹤0.01% 879
2013
Q4
Sell
-16,031
Closed -$212K 960
2013
Q3
$212K Buy
+16,031
New +$189K 0.01% 853

Other funds holding ANGO

Gotham Asset Management's ANGO Position: Q3 2021 in Review

Gotham Asset Management sold out of AngioDynamics (ANGO) in Q3 2021, closing a stake of 10,860 shares — an estimated $295K sold.

Gotham Asset Management first reported a position in ANGO in Q3 2013 and held it in 9 quarters. The position peaked at $1.28M in Q2 2017. 156 funds tracked by Wall St. Rank hold ANGO as of Q3 2021.

  • Gotham Asset Management reported no remaining AngioDynamics position as of Q3 2021 after selling out during the quarter.
  • Gotham Asset Management sold 10,860 AngioDynamics shares in Q3 2021, an estimated $295K.
  • Gotham Asset Management first reported a position in AngioDynamics in Q3 2013 and held it in 9 quarters.
  • Gotham Asset Management's AngioDynamics position peaked at $1.28M in Q2 2017.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2021.

Based on Gotham Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.